Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

  • There is currently no data for APQ

Changes to the Board

7 Jan 2019 13:43

RNS Number : 4063M
APQ Global Limited
07 January 2019
 

7 January 2019

APQ Global Limited

("APQ Global" or the "Company")

Changes to the Board

 

APQ Global Limited, an emerging markets growth company based in Guernsey, announces the appointment of Wesley Davis to its Board as Finance Director, taking over from Richard Bray, who will step down from the Board.

 

Mr. Davis has over 25 years of experience in emerging & frontier markets, both in investment banking and operating company roles. Most recently, Mr. Davis has been serving in a consulting capacity on the International Advisory Council of the Company, with a focus on private equity and illiquid credit origination.

 

Prior to this, Mr Davis assisted emerging & frontier market firms in Africa and Asia with business development and financial advisory services at New Asia Advisory Ltd. Also, he was responsible for international funding and investor relations, while serving as a member of the Board of Directors at Asia Pacific Investment Partners.

 

Mr Davis also has experience in senior roles in emerging markets origination and institutional sales at Renaissance Capital, HSBC Bank and Merrill Lynch.

 

Bart Turtelboom, Chief Executive Officer and Executive Director, commented:

 

"I am delighted to welcome Wesley to the Board. He has already brought his multi-decade experience in emerging & frontier markets to our International Advisory Council and we believe the Company will benefit further from him joining the Board as Finance Director."

 

"Also, I would like to thank Richard for his service to the Board. He made a significant contribution to the Company, having served as Finance Director since the Company's admission to AIM in August 2016.

 

The following information in relation to Mr. Davis is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies.

 

Full name: Wesley Thompson Davis

Age: 52

Shares held: 0

 

Directorships held in the past five years:

Current

N/A

Past

Asia Pacific Investment Partners (2013 to June 2017)

 

Other Disclosures

None

 

 

For further enquiries, please contact:

APQ Global LimitedBart Turtelboom

020 3478 9708

N+1 Singer - Nominated Adviser and BrokerJames Maxwell / Justin McKeegan

020 7496 3000

Carey Group - TISE sponsorClaire Torode

01481 737 279

Buchanan CommunicationsCharles Ryland / Henry Wilson

020 7466 5000

 

Notes to Editors

APQ Global Limited

APQ Global (ticker: APQ LN) is a global emerging markets income company with interests across Asia, Latin America, Eastern Europe, the Middle East and Africa. The Company's objective is to steadily grow earnings to deliver attractive returns and capital growth to shareholders. This objective is achieved through a combination of revenue generating operating activities and investing in growing businesses across emerging markets. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets.

For more information, please visit apqglobal.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEADFXEDNNEFF
Date   Source Headline
16th Nov 20225:00 pmRNSBook Value Report
17th Oct 20227:00 amRNSBook Value Report
17th Oct 20227:00 amRNSBook Value Report
4th Oct 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
29th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
14th Sep 20221:00 pmRNSBook Value Report
16th Aug 202212:00 pmRNSBook Value Report
15th Aug 20224:00 pmRNSChange of Registered Office
10th Aug 202211:00 amRNSResult of AGM
25th Jul 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
15th Jul 202212:30 pmRNSBook value report
11th Jul 20227:00 amRNSNotice of AGM
16th Jun 20227:00 amRNSBook Value Report
1st Jun 20227:00 amRNSFinal results for the year to 31 December 2021
19th May 20227:00 amRNSBook Value Report
27th Apr 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
14th Apr 20228:00 amRNSQuarterly Update
14th Apr 20227:00 amRNSBook Value Report
15th Mar 20227:00 amRNSBook Value Report
21st Feb 20227:00 amRNSBook Value Report
28th Jan 20227:00 amRNSBook Value Report
21st Jan 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
20th Dec 20217:00 amRNSBook Value Report
17th Nov 20217:00 amRNSBook Value Report
11th Nov 20217:00 amRNSRepurchase of Convertible Preference Shares
9th Nov 20217:00 amRNSRepurchase of Convertible Preference Shares
19th Oct 20215:30 pmRNSIssue of Equity and PDMR/Director Shareholding
15th Oct 20217:00 amRNSBook Value Report
30th Sep 20217:00 amRNSInterim results for six months ending 30 June 2021
20th Sep 20217:00 amRNSBook Value Report
1st Sep 20215:30 pmRNSResult of AGM
17th Aug 20217:00 amRNSBook Value Report
11th Aug 20214:15 pmRNSDirector/PDMR Shareholding
11th Aug 20217:01 amRNSNotice of AGM
11th Aug 20217:00 amRNSTrading Update
28th Jul 20217:00 amRNSIssue of Equity and PDMR/Director Shareholding
19th Jul 20217:00 amRNSBook Value Report
15th Jun 20217:00 amRNSBoard Changes
14th Jun 20217:00 amRNSBook Value Report
17th May 20217:00 amRNSBook Value Report
23rd Apr 20214:40 pmRNSSecond Price Monitoring Extn
23rd Apr 20214:35 pmRNSPrice Monitoring Extension
16th Apr 20217:00 amRNSIssue of Equity and PDMR/Director Shareholding
15th Apr 20217:01 amRNSBook Value Report
15th Apr 20217:00 amRNSFinal results for the year to 31 December 2020
7th Apr 20212:05 pmRNSSecond Price Monitoring Extn
7th Apr 20212:00 pmRNSPrice Monitoring Extension
15th Mar 20217:00 amRNSBook value report
15th Feb 20217:00 amRNSBook value report
2nd Feb 20214:15 pmRNSQuarterly Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.